Deadline: August 03, 2026
The 4C Accelerator helps MedTech startups build industry-specific expertise and strengthen their business models for success in the healthcare sector.
Commercialization, certification, clinical studies, copyright, 4C Business Modelling, medical technology, in-vitro diagnostics (IVDs), regulatory requirements, business model development, MDR/IVDR, ISO 13485, GDPR, German reimbursement system, company certification, product approval, reimbursement strategies, innovation protection, personal health data, risk management, clinical study protocols, and intended use documentation.
The 4C Accelerator is designed specifically for startups developing innovative medical devices and in-vitro diagnostics. The programme recognizes that MedTech startups face unique challenges in the healthcare industry and supports founders in addressing these through specialized knowledge and practical business model development.
The programme provides knowledge transfer across the four core areas of Commercialization, Certification, Clinical Studies, and Copyright. It also introduces participants to the proprietary 4C Business Modelling methodology, which helps integrate regulatory requirements into business model development from an early stage.
The qualification programme includes two parts. The first consists of 15 interactive 4C workshops delivered by the Foundation for Medical Innovations. The second offers six months of individual 4C coaching provided by Medical Innovations Incubator GmbH.
Participants will gain practical knowledge on identifying whether a product has a medical effect, determining its classification under MDR/IVDR, understanding applicable standards and regulations, obtaining company certification and product approval, exploring reimbursement opportunities, protecting intellectual property, managing personal health data, and incorporating regulatory requirements into product development and market entry strategies.
The programme also covers regulatory frameworks such as MDR/IVDR, quality management systems according to ISO 13485, risk management according to ISO 14971, clinical study protocols according to ISO 14155, selective contracts, DiGA guidelines, and GDPR. A key component of the programme is the Intended Use Document, which is continuously developed to support strategic business model planning.
For more information, visit Medical Innovations Incubator.
